Rosetta Capital
Europe, England, United Kingdom, London'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
Description
Rosetta Capital Limited is a private equity and venture capital firm specializing in direct secondary investments.
Investor Profile
Rosetta Capital has made 14 investments, with 1 in the past 12 months and 14% as lead.
Stage Focus
- Series Unknown (21%)
- Series C (14%)
- Post Ipo Equity (14%)
- Series A (14%)
- Post Ipo Debt (14%)
- Series D (7%)
- Undisclosed (7%)
- Series B (7%)
Country Focus
- Sweden (36%)
- Switzerland (29%)
- Ireland (7%)
'/%3e%3cpath d='M200 752.362h200v300H200z' style='fill:%23fff;fill-opacity:1;stroke:none' transform='translate(0 -752.362)'/%3e%3cpath d='M400 752.362h200v300H400z' style='fill:%23ff883e;fill-opacity:1;stroke:none' transform='translate(0 -752.362)'/%3e%3c/svg%3e)
- United Kingdom (7%)
- Singapore (7%)
'/%3e%3cuse xlink:href='%23a' transform='translate(288.889 -214.211)'/%3e%3cuse xlink:href='%23a' transform='translate(108 342.749)'/%3e%3cuse xlink:href='%23a' transform='translate(469.189 342.749)'/%3e%3c/svg%3e)
- Germany (7%)
- Norway (7%)
Industry Focus
- Biotechnology
- Health Care
- Pharmaceutical
- Therapeutics
- Biopharma
- Medical
- Manufacturing
- Medical Device
- Life Science
- Health Diagnostics
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
